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Gait Mechanics Differences Between Healthy Controls
and Patients With Peripheral Artery Disease After Adjusting
for Gait Velocity, Stride Length, and Step Width
John D. McCamley,1 Eric L. Cutler,1 Kendra K. Schmid,2 Shane R. Wurdeman,1,3
Jason M. Johanning,2,4 Iraklis I. Pipinos,2,4 and Sara A. Myers1,4
1University of Nebraska Omaha; 2University of Nebraska Medical Center; 3Hanger Inc; 4Omaha VA Medical Center
Patients with peripheral artery disease (PAD) experience significant leg dysfunction. The effects of PAD on gait include
shortened steps, slower walking velocity, and altered gait kinematics and kinetics, which may confound joint torques and power
measurements. Spatiotemporal parameters and joint torques and powers were calculated and compared between 20 patients with
PAD and 20 healthy controls using independent t tests. Separate analysis of covariance models were used to evaluate group
differences after independently adjusting for gait velocity, stride length, and step width. Compared with healthy controls, patients
with PAD exhibited reduced peak extensor and flexor torques at the knee and hip. After adjusting for all covariates combined,
differences between groups remained for ankle power generation in late stance and knee flexor torque. Reduced walking velocity
observed in subjects affected by PAD was closely connected with reductions in joint torques and powers during gait. Gait
differences remained at the knee and ankle after adjusting for the combined effect of spatiotemporal parameters. Improving
muscle function through exercise or with the use of assistive devices needs to be a key tool in the development of interventions
that aim to enhance the ability of PAD patients to restore spatiotemporal gait parameters.
Keywords: intermittent claudication, gait biomechanics, joint torques and powers, walking velocity
Peripheral artery disease (PAD) is a progressive disease caused
by atherosclerotic blockages of the arteries supplying the legs.1
These blockages restrict blood flow to the affected legs and com-
monly present as claudication, exercise-induced cramping pain only
relieved by rest. This presentation is known as intermittent claudi-
cation, and it can affect one or both legs.2,3 Patients with PAD have
reduced physical activity and typically experience diminishedmobil-
ity and quality of life.1,2,4,5 The American Heart Association reports
PAD currently affects more than 8 million Americans, including
over 20% of those aged 65 years and over.6 The incidence of PAD is
currently on the rise7 due to the prevalence of the underlying risk
factors of PAD (eg, high blood pressure, physical inactivity, obesity,
high cholesterol, and diabetes). As a growing public health concern,
a more comprehensive understanding of PAD causal mechanisms is
needed to promote improved functional outcomes.
A notable consequence of PAD is altered spatiotemporal gait
parameters. Patients with PAD have been reported to walk with
decreased step length, cadence, and velocity and with increased
stance time and step width compared with their healthy counter-
parts8; these are present from the first steps the patient takes before
he or she experiences any claudication symptoms.9,10 Similarly,
several studies have revealed altered or abnormal joint torques and
powers, particularly at the ankle and hip, for PAD subjects, both
with and without symptomatic claudication pain.11–14 More spe-
cifically, joint powers are reduced at the hip, knee, and ankle in
patients with PAD compared with velocity-matched controls.14
The reduced peak powers and torques at the ankle in late stance that
have been consistently reported in this pathological population11–13
inhibit patients with PAD from normal forward movement.15
Decreased ankle propulsion was suggested in one of the
earliest studies to explore changes in gait mechanics in patients
with PAD.9 This study found the presence of PAD resulted in
slower walking velocities and shorter steps than age-matched
controls. A 2007 investigation16 reported flattened vertical ground
reaction force curves, reduced forward propulsive forces, and
increased stance time in patients with PAD versus age-matched
controls during overground walking. In a subsequent study, pa-
tients with PAD exhibited increased peak ankle plantar flexion
angle and range of motion during early stance.17 All reported
effects were observed prior to claudication onset.
With multiple spatial–temporal, kinematic, and kinetic gait
mechanics variables altered for patients with PAD, it has proven
difficult to distinguish their relationships with one another. Multi-
ple studies have investigated the relationship between spatiotem-
poral gait variables and moments and powers during walking for
healthy subjects.18–20 A study involving healthy older adults21
showed that spatiotemporal variables, such as stride length and
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gait velocity, were significant confounders for gait measurements.
Studies have also observed the relationship between spatiotempo-
ral changes and diseases such as osteoarthritis and their effect on
kinematic and kinetic parameters.22–25 It is similarly possible that
changes in spatiotemporal measures influence joint torque and
power alterations in PAD gait.
Wurdeman et al14 partially explored the effects of spatiotem-
poral measures by comparing limb joint torques and powers in
patients with PAD to velocity-matched controls. This study found
no significant differences in joint torques at the ankle, knee, or hip.
This contradicts previous work by the same group that did not
account for differences in subjects’ preferred walking velocities
and reported differences in torques at the ankle, knee, and hip.12,13
Joint powers, however, continued to show significant differences14
between the velocity-matched groups. Ankle peak power genera-
tion during late stance, knee peak power absorption in early and late
stance, and hip peak power absorption in midstance were reduced
for patients with PAD. As was noted in the Wurdeman study,14 the
procedure of matching patients with PAD to healthy controls based
on walking velocity may have unintentionally suffered from
selection bias, as those PAD subjects with faster self-selected
walking velocities could be patients with inherently less severe
disease manifestations.
The Wurdeman study14 did not account for potential differ-
ences due to stride length or step width. Thus, the current study
utilized a statistical approach to study the impact of spatiotem-
poral gait differences on kinematic and kinetic parameters. We
determined whether differences in joint torques and powers at the
ankle, knee, and hip, observed between PAD subjects and con-
trols, was a true phenomenon or a secondary effect of changes
in gait velocity, step length, and step width. We hypothesized
that the spatiotemporal covariates were confounding variables of
joint torques and powers between PAD subjects and controls.
This study provided a more comprehensive understanding of
the effects that confounding spatiotemporal measures have on
gait in patients with PAD. Changes in statistical significance for a
variable after adjusting for a covarying spatiotemporal measure
provided insight into the ultimate effect of altered joint torque
or power.
Methods
Subjects
All recruitment, screening, and testing were performed subse-
quent to approval by the Omaha VA Medical Center and the
University of Nebraska Medical Center review boards. All sub-
jects provided informed written consent. Twenty healthy controls
(age: 64.6 [8.0] y, height: 1.75 [0.08] m, mass: 83.8 [12.6] kg) and
20 bilateral PAD subjects (age: 62.6 [6.0] y, height: 1.78 [0.08] m,
mass: 89.2 [15.5] kg) were enrolled in this study. Patients with
PAD were diagnosed and screened for possible comorbidities
(neurological, musculoskeletal, and cardiopulmonary disorders)
at a local vascular surgery clinic. Control subjects were recruited
from the local community. Controls with age, height, and weight
similar to the PAD group mean values were preferred. A personal
medical history was collected and a physical examination and
noninvasive ankle–brachial index screening was performed to
confirm the presence or absence of PAD as well any possible
comorbidities. Subjects from the PAD and control groups were
excluded if they required the use of an assistive device, such as a
cane or walker.
Data Collection
Upon arrival at the laboratory for data collection, subjects were
provided with a form-fitting singlet and athletic footwear. This
garment was necessary for the accurate marking of anatomical
landmarks on the pelvis.14 Standardized athletic footwear was
provided to maintain uniform sole shape and material properties.
The subjects wore a Nike Dart men’s walking shoe of the appro-
priate size. Athletic footwear was used rather than bare feet because
of the high risk of ulcer development in feet of patients with PAD
and to capture the mechanics of subjects with the constraints
imposed in their typical environment. Height, weight, and age
of the subjects were recorded. Reflective markers were placed on
the subject in a modified Helen Hayes marker set arrangement.26
Lower extremity kinetics were collected, at a rate of 600 Hz,
using a Kistler piezoelectric force platform (Kistler North America,
Amherst, NY) mounted flush with the surface of the floor. Lower
extremity kinematics were collected at a rate of 60 Hz using a
Motion Analysis 8-camera motion capture system (Motion Analy-
sis Corp, Santa Rosa, CA).
All subjects walked along a clearly marked 10-m walkway at a
self-selected pace. Five successful overground walking trials were
collected for each leg. A successful trial was completed when
the designated foot (left or right) landed completely within the area
of the force plate. Subjects were required to rest for a minimum
of 1 minute between trials to prevent overexertion and oxygen
deprivation in the lower extremities. This ensured that PAD
subjects did not experience claudication pain while walking.
Data Analysis
During subsequent processing, the marker position data were
smoothed at a cutoff frequency of 6 Hz using a Butterworth
fourth-order low-pass filter. The positions of the reflective markers
and ground reaction forces were utilized to calculate joint kinemat-
ics and kinetics during stance time for each trial. For patients with
PAD, the limb with the lower ankle–brachial index was utilized for
kinetic analysis. For control subjects, the right limb was chosen for
analysis. The marker position data and ground reaction forces were
analyzed using inverse dynamics as described by Vaughan et al27
and Nigg et al28 using Cortex (Motion Analysis Corp) and Visual3D
(C-Motion Inc, Germantown, MD) software. A customMATLAB®
(MathWorks Inc, Natick, MA) program was used to determine peak
joint kinetics for each trial. Variables that were included for the
analysis were the following peak joint torques: ankle dorsiflexor,
ankle plantar flexor, knee extensor, knee flexor, hip extensor, and
hip flexor. Dorsiflexion was defined as a movement of the forefoot
toward the shank, and plantar flexion was defined as a movement of
the forefoot away from the shank. Flexion was defined as a decrease
in the corresponding joint angle, and extension was defined as an
increase in the corresponding joint angle. In addition, the following
joint powers were calculated: ankle power absorption in early stance
(A1), ankle power generation in late stance (A2), knee power
absorption in early stance (K1), knee power generation in early
stance (K2), knee power absorption in late stance (K3), hip power
generation in early stance (H1), hip power absorption in midstance
(H2), and hip power generation in late stance (H3).
Statistical Analysis
An independent t test was used to compare joint torques and powers
between controls and PAD subjects through univariate analysis.
Separate analysis of covariance models was used to evaluate the
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association of a condition with the outcome (joint torques or
powers), adjusting for velocity, step width, and step length. An
alpha value less than .05 was considered statistically significant.
Results
The initial t test found that control subjects walked significantly
faster than patients with PAD (Table 1). The t test also revealed
significant differences for 8 of the 14 dependent variables. Signifi-
cant differences in both peak extensor and flexor torque values
were found at the knee and hip. Peak power differences were
observed for ankle power generation in late stance, knee power
absorption and generation during early stance, and knee power
absorption during late stance.
Each of the 3 spatiotemporal variables was input individually
as a covariate, as well as all 3 variables in combination. The
inclusion of each of these covariates had an effect on which of the
dependent variables exhibited statistically significant differences
(Table 2).
Adjusting for step width as a covariate had little effect on the
variables that were significantly different. All previous differences
observed for the univariate analysis (KET, KFT, HET, HFT, A2,
K1, K2, and K3) remained significant, with an additional difference
in peak ankle plantar flexor torque observed. Adjusting for stride
length had a greater effect, with significant differences no longer
apparent for peak knee extensor torque or knee power absorption
during early stance. The covariate which had the greatest effect on
lower limb kinetic differences during stance was velocity. After
adjusting for velocity, peak knee flexor torque, peak hip extensor
torque, and peak hip flexor torque were significantly different
between patients with PAD and the control subjects.
After adjusting for the combination of all 3 spatiotemporal
variables (stride length, step width, and velocity) as covariates, the
only significant differences that remained were for knee flexor
torque and ankle power generation in late stance.
Discussion
This study sought to examine whether known spatiotemporal
differences in patients with PAD are driving gait alterations
in peak joint torques and powers at the ankle, knee, and hip.
Previously, little work has been performed to determine how the
changes in spatiotemporal variables that are observed for patients
with PAD confound the changes in kinetic variables that are also
observed during walking. We statistically controlled for gait
velocity, step length, and step width differences between the
patients with PAD and control groups. In our study, these covari-
ates affected the statistical significance of certain gait variables,
while most differences remained even after the adjustment.
Ankle power generation in late stance, in particular, was no
longer different for PAD subjects compared with controls after
accounting for velocity alone. This would appear to confirm the
role of ankle push-off power in generating forward motion and
suggests that a reduction in ankle power is at least a partial
contributor to the reduction of walking velocity observed in
patients with PAD. This was expected because power, by defini-
tion, is the product of angular velocity (rate of movement) and joint
Table 1 Univariate Comparison Between Patients
With PAD and Healthy Age-Matched Controls
Control PAD t test
Dependent variable Mean (SD) Mean (SD) P value
Stride length, mm 1488 (113) 1428 (87) .07
Step width, mm 112 (27) 120 (22) .28
Velocity, m·s−1 1.32 (0.12) 1.24 (0.07) .02*
ADT 0.35 (0.09) 0.30 (0.11) .15
APT 1.46 (0.21) 1.35 (0.12) .06
KET 0.78 (0.25) 0.59 (0.20) .01*
KFT 0.11 (0.13) 0.20 (0.10) .02*
HET 0.92 (0.22) 0.74 (0.24) .02*
HFT 1.10 (0.22) 0.94 (0.18) .02*
A1 0.83 (0.26) 0.76 (0.30) .42
A2 2.89 (0.82) 2.27 (0.33) .01*
K1 1.11 (0.55) 0.78 (0.30) .03*
K2 0.57 (0.32) 0.35 (0.19) .01*
K3 1.30 (0.61) 0.91 (0.28) .02*
H1 0.69 (0.30) 0.34 (0.20) .10
H2 0.90 (0.24) 0.75 (0.24) .05
H3 0.99 (0.20) 0.87 (0.22) .08
Abbreviations: A1, ankle power absorption in midstance; A2, ankle power
generation in late stance; ADT, ankle dorsiflexor torque; APT, ankle plantar
flexor torque; H1, hip power generation in early stance; H2, hip power absorption
in midstance; H3, hip power generation in late stance; HET, hip extensor torque;
HFT, hip flexor torque; K1, knee power absorption in early stance; K2, knee power
generation in early stance; K3, knee power absorption in late stance; KET, knee
extensor torque; KFT, knee flexor torque; PAD, peripheral artery disease. Notes:
All variables are peak values. All torques are reported in N m·kg−1 and power in
W·kg−1. Stride length and step width are reported in mm and velocity in m·s−1.
*Significant difference (P < .05) between groups.
Table 2 Significance (P Value) Level for 4 Independent
ANCOVA Analyses
Covariate All Stride length Step width Velocity
ADT .94 .47 .27 .57
APT .14 .28 .02* .26
KET .18 .06 .02* .12
KFT .04* .01* .03* .03*
HET .07 .03* .03* .045*
HFT .07 .04* .03* .05*
A1 .14 .41 .33 .17
A2 .04* .02* .003* .06
K1 .27 .13 .03* .24
K2 .12 .048* .01* .10
K3 .13 .03* .02* .16
H1 .11 .09 .09 .14
H2 .18 .13 .06 .14
H3 .25 .09 .09 .29
Abbreviations: A1, ankle power absorption in midstance; A2, ankle power
generation in late stance; ADT, ankle dorsiflexor torque; ANCOVA, analysis
of covariance; APT, ankle plantar flexor torque; H1, hip power generation in early
stance; H2, hip power absorption in midstance; H3, hip power generation in late
stance; HET, hip extensor torque; HFT, hip flexor torque; K1, knee power
absorption in early stance; K2, knee power generation in early stance; K3,
knee power absorption in late stance; KET, knee extensor torque; KFT, knee
flexor torque. Notes: Peak values of dependent variables are reported. The
comparisons between healthy controls and patients with PAD were statistically
adjusted for stride length, step width, and walking velocity independently and all 3
combined (All).
*Significant difference (P < .05) between groups.
JAB Vol. 35, No. 1, 2019
Gait Covariates in Peripheral Artery Disease 21
D
ow
nl
oa
de
d 
by
 U
N
IV
 O
F 
N
E 
A
T 
O
M
A
H
A
 o
n 
02
/0
6/
19
torque (force causing movement) during walking. As walking
velocity decreases, the angular velocity of the ankle will likely
decrease. It is important to note that angular velocities of the lower
extremity joints are not the same as walking velocity. While some
differences between groups in each of those rates is expected, it
may not be proportionate to differences in walking velocity. Even
though ankle power generation did not remain significantly differ-
ent between PAD and controls after adjusting for walking velocity
alone, it was different when adjusting for stride length alone, step
width alone, and the combination of stride length, step width, and
velocity. Considering there were no significant differences in stride
lengths or step widths, but velocity was decreased in patients with
PAD, our results suggest that patients with PAD have reduced
ankle power generation compared with healthy individuals.
Accounting for velocity and stride length had inconsistent
effects on torques at the knee. While peak knee extensor torques
were no longer significantly different when the results were
adjusted for velocity or stride length, significant differences in
peak knee flexor torques remained after adjustment for all covari-
ates. It appears that the observed differences in knee extensor
torques during stance are at least in part a consequence of the lower
walking velocity and reduced stride length of patients with PAD.
This is not the case for knee flexor torques, which remain signifi-
cantly greater after adjustment for the combination of covariates.
This is in accordance with the results reported by Lelas et al,20 who
found a strong relationship between knee flexor torque during
stance and walking velocity, but not between knee extensor torque
and velocity, for healthy subjects. These altered torques at the knee
may also help explain the altered vertical ground reaction force
profile during midstance observed previously,16 where patients
with PAD had an increased vertical force during midstance.
Adjustment for walking velocity alone removed the significant
differences in all knee joint power peaks. This suggests that the
lower powers measured at the knee account for lesser velocities
observed in the PAD subjects.20While reduced power absorption at
the knee was observed in a study that utilized velocity-matched
subjects,14 reduced knee power absorption was not apparent when
velocity was accounted for in this study. If the subjects with PAD in
this study had reduced power absorption at the knee, this was
masked by differing knee power requirements of altered walking
velocity. It is possible that our previous study using velocity-
matched subjects led to selecting healthy controls who naturally
walked slower and patients with PAD who naturally walked
faster.14 It is also possible that 20 subjects per group is not adequate
for investigating multiple confounders.
In this study, hip torque differences between groups were not
affected by controlling for step width or step length alone, but there
were no longer differences in hip torques after controlling for the 3
combined covariates. We also did not observe differences in hip
power requirements. This partially agrees with previous findings,14
which found no differences in hip power generation for velocity-
matched subjects.
It appears from these results that the ability of the distal lower
limb musculature to generate propulsive power may be weakened
by the presence of PAD. Such morphological and functional
changes are supported through extensive research that has demon-
strated muscle atrophy, mitochondrial dysfunction,29–31 and
reduced limb strength.32 When patients with PAD pushed against
a footplate,33 they were observed to have poorer leg extensor
muscle power than subjects without PAD. An association has
also been shown between lower ankle–brachial index values and
lower isometric plantar flexion strength, and knee extensor
strength.34 It is possible that this decreased muscle performance
results in decreased walking velocity. It may also be that patients
with PAD reduce their walking velocity to prolong the time to
claudication, thus resulting in lower knee joint powers. It is difficult
to directly detect which is the case, and it is also possible that both
scenarios take place concurrently. Recent studies have demon-
strated that, when compared with healthy controls, joint powers are
altered in individuals with PAD even before claudication is expe-
rienced.8,10 This suggests that the affected limb might be physically
limited from generating the powers required to walk at velocities
similar to healthy controls, and that reduced walking velocity is not
simply a strategy to avoid claudication.
This study controlled for the effect of velocity as well as
stride length and step width mathematically, using the analysis of
covariance statistic. The statistical method of correcting for gait
velocity yielded results similar to using subjects with the same gait
velocity. When comparing subsets of healthy subjects and patients
with PAD who naturally walk at the same speed, there were no
differences in joint torque variables but multiple differences in
powers. These results were most consistent with the current
comparison that adjusted for all variables (velocity, stride length,
and step width). In the other comparisons from this study, differ-
ences were found primarily for torque variables. Thus, the statisti-
cal approach can be complementary and provide different insights
regarding group differences and the impact of spatial temporal
characteristics. Overall, this study reinforces previous studies
emphasizing the importance of ankle function in late stance and
knee torque as essential contributors to walking velocity. A more
detailed investigation to determine how the timing of the altered
joint torques and powers are interrelated is necessary to fully
understand the consequences muscle function changes due to
PAD have on walking.
The results of this study show that the changes to spatiotemporal
parameters of gait (stride length, step width, and velocity) observed
in subjects affected by PAD are tightly interrelated with measurable
joint torques and powers of the lower limbs during gait. This
highlights the need to carefully interpret how measured changes
in the spatial and temporal features of walking are explained by
differing joint kinetics, which are in turn caused by altered lower
limb muscle function as a consequence of PAD. Many of the
changes observed in gait characteristics of patients with PAD are
already observed in older persons but to a greater degree. It has
already been shown that aging causes a proximal change in joint
torques and powers.35 PAD has an effect on the distal musculature of
the lower limbs, so it is no surprise that it will cause gait changes
similar to, but of greater magnitude than, those already observed in
the elderly. This study highlights the importance of taking into
consideration secondary changes to gait patterns when assessing the
effect of pathologies that effect walking mechanics. Future studies
are necessary to further determine howPAD changes specificmuscle
function in the lower limbs and limits the ambulation of PAD
patients. Improving muscle function through exercise or with the
use of assistive devices needs to be a key tool in the development of
any intervention that aims to enhance the ability of PAD patients to
restore spatiotemporal gait parameters.
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